Acorn Bioventures, L.P.

Related company / holding

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€447k

▼ Sales (0 ops.)

—

Latest filing published 19 May 2025 for OnKure Therapeutics, Inc., €447k. Read the official filing

Filing timeline

BuySale

Acorn Bioventures, L.P.

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

OnKure Therapeutics, Inc. 1 purchase · last 19 May 2025

Since each purchase

OnKure Therapeutics, Inc.
Filed 19 May 2025 · 517 days ago · €447k
+53.4%
Entry US$2.32 · Close at T+365 US$3.56

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Acorn Bioventures, L.P.: trading record in brief

Our data holds just one disclosure by Acorn Bioventures, L.P., dated 19 May 2025, reporting an open-market purchase worth €447k in OnKure Therapeutics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.